ANXA1 and arthritic joint disease: Having established this clinically relevant model of diastolic dysfunction associated with arthritis, we then investigated the potential beneficial effects of human recombinant AnxA1 (hrAnxA1) against the diastolic dysfunction of K/BxN F1 mice.